{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:45:57Z","timestamp":1785735957159,"version":"3.56.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Rheumatoid arthritis (RA) is a globally prevalent, chronic, systemic disorder of articular joints, with an auto-immune etiology, which eventually leads to physical disability. Peedanil Gold (PG), an Ayurvedic herbo-mineral medicine, has demonstrated anti-inflammatory activity in\n                      <jats:italic>in vitro<\/jats:italic>\n                      assays. Furthermore, it has also exhibited pharmacological effects in animal models of osteoarthritis and neuropathic pain. The present study was specifically designed to assess the preclinical anti-arthritic potential of Peedanil Gold in a well-established murine model of arthritis, induced by the administration of collagen antibodies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, BALB\/c mice were intraperitoneally induced with a cocktail of five monoclonal antibodies against Type II collagen epitopes, followed by lipopolysaccharide. Peedanil Gold was administered as a gavage post-initiation of disease induction. Orally administered methotrexate (MTX) was used as a method control. Animals were humanely sacrificed on 13th day, post-antibody induction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Collagen antibodies led to the development of arthritis in animals, evident as swelling of the paws and ankles. Arthritis scoring of animals revealed that Peedanil Gold could alleviate the arthritic symptoms in a dose-related manner, with the highest dose demonstrating maximal pharmacological effects. Similarly, paw and ankle thicknesses were also reduced post-treatment with Peedanil Gold, signifying reduction in inflammatory changes in paw and ankle regions. Disease-modifying effects of Peedanil Gold were additionally substantiated by radiological observations of decreased soft tissue swelling and cartilage erosion with treatment. Furthermore, histopathological analysis of the knee and ankle demonstrated that treatment with Peedanil Gold could diminish the disease-evoked pathological alterations, such as bone degeneration and inflammatory cell infiltration. Peedanil Gold could also attenuate the elevated serum levels of interleukin 6 (IL-6).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The outcomes of the present experiments demonstrate that Peedanil Gold has pharmacological effects in an animal model of rheumatoid arthritis, as evident by reduced arthritis score, alleviation of paw and ankle swelling, improvement in pathological lesions as observed radiologically and histopathologically. Consequently, it possesses preclinical potential for the management of rheumatoid arthritis, which warrants detailed investigations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1868253","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:30:09Z","timestamp":1785735009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Peedanil Gold attenuates IL-6-mediated articular pathologies in a collagen antibody-induced murine model of rheumatoid arthritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Acharya","family":"Balkrishna","sequence":"first","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Foundation","place":["Haridwar, India"]},{"name":"Department of Allied and Applied Sciences, University of Patanjali","place":["Haridwar, India"]},{"name":"Patanjali United Kingdom Trust","place":["Glasgow, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Sharma","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Foundation","place":["Haridwar, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aakanksha","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Foundation","place":["Haridwar, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Sinha","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Foundation","place":["Haridwar, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Varshney","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Foundation","place":["Haridwar, India"]},{"name":"Department of Allied and Applied Sciences, University of Patanjali","place":["Haridwar, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.imbio.2016.10.001","article-title":"STA-21, a STAT-3 inhibitor, attenuates the development and progression of inflammation in collagen antibody-induced arthritis","volume":"222","author":"Ahmad","year":"2017","journal-title":"Immunobiol"},{"key":"B2","first-page":"1","volume-title":"Arthritogenic Monoclonal Antibody","year":"2022"},{"key":"B47","year":"2010","journal-title":"Ayurved Sar Sangrah, Edition 2010"},{"key":"B3","doi-asserted-by":"publisher","first-page":"110985","DOI":"10.1016\/j.biopha.2020.110985","article-title":"Gallic acid: pharmacological activities and molecular mechanisms involved in inflammation-related diseases","volume":"133","author":"Bai","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fphar.2019.00659","article-title":"Anti-inflammatory and anti-arthritic efficacies of an Indian traditional Herbo-Mineral medicine \u201cDivya Amvatari Ras\u201d in collagen antibody-induced arthritis (CAIA) mouse model through modulation of IL-6\/IL-1\u03b2\/TNF-\u03b1\/NF\u03baB signaling","volume":"10","author":"Balkrishna","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"883475","DOI":"10.3389\/fphar.2022.883475","article-title":"Peedanil gold, Herbo-Mineral formulation, moderates cytokine levels and attenuates pathophysiology in monosodium iodoacetate induced osteoarthritis in SD rat model","volume":"13","author":"Balkrishna","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6982170","DOI":"10.1155\/prm\/6982170","article-title":"Herbomineral medicine peedanil gold exerts analgesia in neuropathy by moderating inflammatory response and TRP channel expression in sprague dawley rat surgical chronic constriction injury model","volume":"2025","author":"Balkrishna","year":"2025","journal-title":"Pain Res. Manag."},{"key":"B7","first-page":"92","article-title":"Evaluation of a candidate anti-arthritic drug using the mouse collagen antibody induced arthritis model and clinically relevant biomarkers","volume":"5","author":"Bender","year":"2013","journal-title":"Am. J. Transl. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1136\/annrheumdis-2018-213289","article-title":"Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry","volume":"77","author":"Bergstra","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/s2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021","volume":"5","author":"Black","year":"2023","journal-title":"Lancet Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/bor.0000000000000452","article-title":"Rheumatoid arthritis and citrullination","volume":"30","author":"Darrah","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"B12","volume-title":"Compendium of CPCSEA","year":"2018"},{"key":"B13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/1061186x.2018.1433680","article-title":"Drug delivery targets and systems for targeted treatment of rheumatoid arthritis","volume":"26","author":"Feng","year":"2018","journal-title":"J. Drug Target"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e509","DOI":"10.1002\/mco2.509","article-title":"Rheumatoid arthritis: pathogenesis and therapeutic advances","volume":"5","author":"Gao","year":"2024","journal-title":"MedComm (2020)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7385106","DOI":"10.1155\/2021\/7385106","article-title":"New studies of pathogenesis of rheumatoid arthritis with collagen-induced and collagen antibody-induced arthritis models: new insight involving bacteria flora","volume":"2021","author":"Hashida","year":"2021","journal-title":"Autoimmune Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jim.2009.01.009","article-title":"Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies","volume":"343","author":"Hutamekalin","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/intimm\/dxr057","article-title":"Tyk2 deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice","volume":"23","author":"Ishizaki","year":"2011","journal-title":"Int. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/ijms23020905","article-title":"Rheumatoid arthritis: pathogenic roles of diverse immune cells","volume":"23","author":"Jang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/nu11122959","article-title":"Anti-arthritic activities of supercritical carbon dioxide extract derived from radiation mutant Perilla frutescens Var. Crispa in collagen antibody-induced arthritis","volume":"11","author":"Jin","year":"2019","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","first-page":"952943","DOI":"10.1155\/2014\/952943","article-title":"A review on protocatechuic acid and its pharmacological potential","volume":"2014","author":"Kakkar","year":"2014","journal-title":"ISRN Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1568010054022114","article-title":"Neutrophil-derived cytokines: potential therapeutic targets in inflammation","volume":"4","author":"Kasama","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"key":"B22","article-title":"Rheumatoid arthritis","volume-title":"Conn\u2019s Current Therapy","author":"Kayanaugh","year":"2018"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/nprot.2006.393","article-title":"Collagen antibody-induced arthritis","volume":"1","author":"Khachigian","year":"2006","journal-title":"Nat. Protoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00000441-200404000-00006","article-title":"Type II collagen autoimmunity in rheumatoid arthritis","volume":"327","author":"Kim","year":"2004","journal-title":"Am. J. Med. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0194331","DOI":"10.1371\/journal.pone.0194331","article-title":"N-3 polyunsaturated fatty acids restore Th17 and treg balance in collagen antibody-induced arthritis","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24020275","article-title":"5-Hydroxymethylfurfural mitigates lipopolysaccharide-stimulated inflammation via suppression of MAPK, NF-\u03baB and mTOR activation in RAW 264.7 cells","volume":"24","author":"Kong","year":"2019","journal-title":"Molecules"},{"key":"B27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1476-9255-8-31","article-title":"Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity","volume":"8","author":"Koobkokkruad","year":"2011","journal-title":"J. Inflamm. (Lond)."},{"key":"B28","doi-asserted-by":"publisher","first-page":"119921","DOI":"10.1016\/j.lfs.2021.119921","article-title":"Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives","volume":"284","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/biology11071058","article-title":"Effects of corilagin on lipopolysaccharide-induced acute lung injury via regulation of NADPH oxidase 2 and ERK\/NF-\u03baB signaling pathways in a mouse model","volume":"11","author":"Liu","year":"2022","journal-title":"Biol. (Basel)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12967-014-0285-z","article-title":"Collagen II antibody-induced arthritis in Tg1278TNFko mice: optimization of a novel model to assess treatments targeting human TNF\u03b1 in rheumatoid arthritis","volume":"12","author":"Moore","year":"2014","journal-title":"J. Transl. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"B32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-59745-402-5_16","article-title":"Collagen antibody induced arthritis","volume":"136","author":"Nandakumar","year":"2007","journal-title":"Methods Mol. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"R544","DOI":"10.1186\/ar1217","article-title":"Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells","volume":"6","author":"Nandakumar","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s00776-015-0768-7","article-title":"Hyperleptinemia suppresses aggravation of arthritis of collagen-antibody-induced arthritis in mice","volume":"20","author":"Okano","year":"2015","journal-title":"J. Orthop. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.35702\/nano.10018","article-title":"A comprehensive review on pharmacological activities of ellagic acid and its applications","volume":"6","author":"Paruvu","year":"2025","journal-title":"Nanoparticle"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184367","article-title":"Animal models of inflammation for screening of anti-inflammatory drugs: implications for the discovery and development of phytopharmaceuticals","volume":"20","author":"Patil","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1177\/0271678x20943823","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"40","author":"Percie du Sert","year":"2020","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","volume":"10","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"138039","DOI":"10.1155\/2015\/138039","article-title":"Pharmacology and phytochemistry of oleo-gum resin of Commiphora wightii (guggulu)","volume":"2015","author":"Sarup","year":"2015","journal-title":"Sci. (Cairo)."},{"key":"B48","author":"Sharma","year":"2004","journal-title":"Rasa Tarangini. Edition 2004"},{"key":"B40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5625\/lar.2016.32.3.135","article-title":"Assessment of collagen antibody-induced arthritis in BALB\/c mice using bioimaging analysis and histopathological examination","volume":"32","author":"Sim","year":"2016","journal-title":"Lab. Anim. Res."},{"key":"B41","first-page":"1","article-title":"A critical review on Guggulu [Commiphora wightii (Arn.) Bhand.] and its miraculous medicinal uses","volume":"3","author":"Singh","year":"2015","journal-title":"Int. J. Ayurveda Pharma Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/ph18081141","article-title":"Pharmacological potential of cinnamic acid and derivatives: a comprehensive review","volume":"18","author":"Tian","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/imr.12829","article-title":"Autoantibodies and B cells: the ABC of rheumatoid arthritis pathophysiology","volume":"294","author":"Volkov","year":"2020","journal-title":"Immunol. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.bbiosy.2021.100030","article-title":"Collagen type II: from biosynthesis to advanced biomaterials for cartilage engineering","volume":"4","author":"Wu","year":"2021","journal-title":"Biomater. Biosyst."},{"key":"B45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3892\/br.2020.1392","article-title":"Flare-up of cytokines in rheumatoid arthritis and their role in triggering depression: shared common function and their possible applications in treatment","volume":"14","author":"Zhang","year":"2021","journal-title":"Biomed. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bioactmat.2025.04.026","article-title":"Angiogenesis in rheumatoid arthritis: pathological characterization, pathogenic mechanisms, and nano-targeted therapeutic strategies","volume":"50","author":"Zhao","year":"2025","journal-title":"Bioact. Mater."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1868253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:30:11Z","timestamp":1785735011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1868253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":48,"alternative-id":["10.3389\/fphar.2026.1868253"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1868253","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"article-number":"1868253"}}